Injectable Semaglutide has not been evaluated by the FDA, but side effects are expected to be similar to other Semaglutide-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)
Some peptides occur naturally in the body
Blood lead levels in relation to smoking and chronic obstructive pulmonary disease (COPD): A study from Korean National Health and Nutrition Examination Survey (KNHANES) J
How often to take FDA-approved oral GLP-1 tablets Once a day